Cover image of the article: Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

Image Credit:J Inflamm Dis

Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

Authors

R Najafipour,*, O Pavelovna
*Corresponding Author: Email: rnajafipour@mail.com

Journal of Inflammatory Diseases:Vol. 12, issue 1; 52-58
Published online:Jun 30, 2008
Article type:Research Article
How to Cite:Najafipour R, Pavelovna O. Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure. J Inflamm Dis. 2024;12(1):e155378. doi:

Abstract

¯Abstract Background: Heart failure is the main cause of morbidity and mortality worldwide with poor prognosis. Two processes inflammation and apoptosis, play major roles in the pathogenesis of heart failure with poor prognosis. Apoptosis can be discovered in different conditions within the myocardial tissues. One of the regulatory mechanisms of apoptosis is through Fas (CD95)/FasL system. Objective: Evaluating the level of soluble markers of Fas/FasL apoptosis system in patients with heart failure and its severity. Methods: This was a case-control study in which 85 patients with different functional class of heart failure and 25 healthy persons as control group were examined at Transplantation Institute of Moscow between the years 2004-2007. Evaluation of apoptosis markers was carried out by immunoferment analysis using an automatic analyzer (Personal Lab TM, Adaltis, Italy) and the Bender Med system kits, Austria. Findings: In patients with heart failure while the blood level of sFas was lower than that of healthy person, the sFasL was found to be higher compared to control group. Regarding the level of soluble forms of apoptotic markers of sFas/sFasL in HF, the sFas and sFasL levels were demonstrated to have an opposite association with the functional class of heart failure so that a negative relationship for sFas and a positive correlation for sFasL were found. At the same time, the sFas was shown to be weakly associated with ejection fraction whereas the sFasL demonstrated a reverse correlation (P<0.05). Conclusion: These markers could be used as complementary laboratory markers to assess the severity of heart failure and also the prognosis.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

30
Sep
2014
Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Alexander Berezin,
Alexander A. Kremzer,
Tatayna A. Samura,
Yulia V. Martovitskaya

Berezin A, Kremzer AA, Samura TA, Martovitskaya YV. Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes. Int Cardiovasc Res J. 2017;8(3):e11090. doi:

19
Jan
2020
Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry

Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry

Rabeah Zamani,
Maryam Chenaghlou,
Zeinab Norouzi,
Mohammad Mostafa Ansari Ramandi,
Sepideh Taghavi,
Ahmad Amin
,et al.

Zamani R, Chenaghlou M, Norouzi Z, Ansari Ramandi MM, Taghavi S, et al. Clinical and Laboratory Predictors of Mortality in Patients with Advanced Heart Failure (Stage D), Data Derived from Rajaie Acute Systolic Heart Failure (RASHF) Data Registry. Multidiscip Cardio Annal. 2020;11(1):e98039. doi: https://doi.org/10.5812/mca.98039

31
Dec
2015
Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Alexander Berezin,
Alexander A. Kremzer

Berezin A, Kremzer AA. Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure. Int Cardiovasc Res J. 2017;9(4):e10873. doi: https://doi.org/10.17795/icrj-9(4)203

1
Dec
2014
Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure

Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure

Roya Atabakhshian,
Faranak Kazerouni,
Fariba Raygan,
Hushang Amirrasouli,
Ali Rahimipour,
Nezhat Shakeri

Atabakhshian R, Kazerouni F, Raygan F, Amirrasouli H, Rahimipour A, et al. Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure. Int Cardiovasc Res J. 2017;8(4):e11675. doi:

15
Jun
2020
Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Maryam Nabati,
Soheil Bakhshinasab,
Ali asghar Farsavian,
Fatemeh Rasolpor,
Jamshid Yazdani- Charati

Nabati M, Bakhshinasab S, Farsavian AA, Rasolpor F, Yazdani- Charati J. Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure. Int Cardiovasc Res J. 2020;14(2):e103597. doi:

More by these authors

R NajafipourPubMedScholar
O PavelovnaPubMedScholar
Share
Cited by
Metrics